Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8
Authors
Keywords
TLR4, Paclitaxel, Breast cancer, Melanoma, Tumor microenvironment, Compound A
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-27
DOI
10.1186/s12885-018-4155-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nab-paclitaxel for the treatment of triple-negative breast cancer: Rationale, clinical data and future perspectives
- (2016) Francesco Schettini et al. CANCER TREATMENT REVIEWS
- Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma
- (2015) Tommaso Azzarito et al. CANCER LETTERS
- Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression
- (2015) Yichun Zheng et al. MOLECULAR ENDOCRINOLOGY
- Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells
- (2014) Feifei Xu et al. Cancer Cell International
- Paclitaxel Therapy Promotes Breast Cancer Metastasis in a TLR4-Dependent Manner
- (2014) L. Volk-Draper et al. CANCER RESEARCH
- Biomarker Analysis of Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early-Stage Breast Cancer
- (2013) C. E. Horak et al. CLINICAL CANCER RESEARCH
- Lipopolysaccharide-Induced Toll-Like Receptor 4 Signaling in Cancer Cells Promotes Cell Survival and Proliferation in Hepatocellular Carcinoma
- (2013) Lili Wang et al. DIGESTIVE DISEASES AND SCIENCES
- Silencing of X-Linked Inhibitor of Apoptosis Decreases Resistance to Cisplatin and Paclitaxel but Not Gemcitabine in Non-Small Cell Lung Cancer
- (2013) Y Liu et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer
- (2013) S. Rajput et al. MOLECULAR CANCER THERAPEUTICS
- TLR4 induces tumor growth and inhibits paclitaxel activity in MyD88-positive human ovarian carcinoma in vitro
- (2013) AN-CONG WANG et al. Oncology Letters
- Prognostic Role of Interleukin-6, Interleukin-8, and Leptin Levels According to Breast Cancer Subtype
- (2013) Young Ae Cho et al. Cancer Research and Treatment
- Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production
- (2012) Zhi Shi et al. BREAST CANCER RESEARCH AND TREATMENT
- Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells
- (2012) Alexander Yemelyanov et al. CELL CYCLE
- Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies
- (2012) Ekaterina Lesovaya et al. CELL CYCLE
- Interleukin-8 secretion by ovarian cancer cells increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasion
- (2012) Yue Wang et al. CYTOKINE
- Icariside II potentiates paclitaxel-induced apoptosis in human melanoma A375 cells by inhibiting TLR4 signaling pathway
- (2012) Jinfeng Wu et al. FOOD AND CHEMICAL TOXICOLOGY
- Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion
- (2012) Huan Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Antitumor effect of non-steroid glucocorticoid receptor ligand CpdA on leukemia cell lines CEM and K562
- (2011) E. A. Lesovaya et al. BIOCHEMISTRY-MOSCOW
- Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration
- (2011) Sheng-Jun Liao et al. BREAST CANCER RESEARCH AND TREATMENT
- A microarray based expression profiling of paclitaxel and vincristine resistant MCF-7 cells
- (2011) Meltem Demirel Kars et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis
- (2010) Salomé González-Reyes et al. BMC CANCER
- A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma
- (2010) Lisa A. Kottschade et al. CANCER
- Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence
- (2010) Salomé González-Reyes et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- X-linked Inhibitor of Apoptosis: A Chemoresistance Factor or a Hollow Promise
- (2010) H. Kashkar CLINICAL CANCER RESEARCH
- Role of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells
- (2009) A. C. Wang et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Toll-like Receptor 4 Signaling Promotes Tumor Growth
- (2009) Che-Hsin Lee et al. JOURNAL OF IMMUNOTHERAPY
- TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer
- (2009) M Szajnik et al. ONCOGENE
- Targeting the p27 E3 ligase SCFSkp2 results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy
- (2008) Q. Chen et al. BLOOD
- Novel Steroid Receptor Phyto-Modulator Compound A Inhibits Growth and Survival of Prostate Cancer Cells
- (2008) A. Yemelyanov et al. CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started